Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Guangkuo Zhu"'
Autor:
Yongdong Feng, Guangkuo Zhu, Song Lang, Ping Hao, Guanghui Li, Fanglin Chen, Wenlei Zhuo, Yuzhong Duan, Anmei Zhang, Zhengtang Chen, Jianguo Sun
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
ObjectiveTo explore the efficacy and safety of EGFR-TKI combined with thymosin therapy in advanced non-small cell lung cancer (NSCLC) patients harboring active EGFR mutations.MethodsPatients confirmed as advanced NSCLC with active EGFR mutations were
Externí odkaz:
https://doaj.org/article/a2e03209f6d243eca9fad3f1912db3be
Autor:
Huake Sun, Huiwen Ma, Jianmin Wang, Liqin Xia, Guangkuo Zhu, Zhoufei Wang, Jianguo Sun, Zhengtang Chen
Publikováno v:
Tumor Biology, Vol 39 (2017)
Acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors, such as gefitinib and erlotinib, is a critical issue in the treatment of patients with epidermal growth factor receptor mutant–positive non–small-cell lung cancer
Externí odkaz:
https://doaj.org/article/cd83a5a4cd254f6cb6b12213e824e80a
Autor:
Qiao Yang, Jianmin Wang, Jianguo Sun, Guangkuo Zhu, Li-Ying Chen, Linpeng Zheng, Mingjing Chen, Zihan Xu, Zhengtang Chen
Publikováno v:
OncoTargets and Therapy. 12:8873-8877
A new progression pattern, hyperprogressive disease (HPD), has been recently acknowledged in cancer patients accepted immune checkpoint inhibitors (ICIs). We report a unique case of cervical small cell carcinoma which showed primary resistance to pem
Autor:
Yinfeng Wang, Haijun Chen, Ying Gao, Chong Zhu, Chuanhua Liao, Guangkuo Zhu, Chen Lu, Jiayu Xu, Yuezhao Zhu, Li Yang
Publikováno v:
Fuel. 244:479-491
The characteristics of hydrochars of cotton stalk (CS) and hydrochar pellets were investigated in this paper to obtain high quality biomass fuel. The differences between the characteristics of hydrochars at different temperatures (180–300 °C) and
Autor:
Zhengtang Chen, An-Mei Zhang, Wenlei Zhuo, Song Lang, Guanghui Li, Jianguo Sun, Ping Hao, Guangkuo Zhu, Yuzhong Duan, Yongdong Feng, Fanglin Chen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
ObjectiveTo explore the efficacy and safety of EGFR-TKI combined with thymosin therapy in advanced non-small cell lung cancer (NSCLC) patients harboring active EGFR mutations.MethodsPatients confirmed as advanced NSCLC with active EGFR mutations were
Autor:
Hui Xu, Gao Ying, Jyotirmoy Sarma, Lian Ji, Jing Wang, Jiayu Xu, Yinghui Liu, Qiaoxia Yuan, Yuezhao Zhu, Yinfeng Wang, Guangkuo Zhu
Publikováno v:
Energy. 165:662-672
In this study, microwaves were introduced into the hydrothermal carbonization (HTC) of high-moisture biomass dairy manure (DM). Experiments were conducted to investigate the effect of reaction temperature and residence time on the distribution and ch
Publikováno v:
Journal of Thermal Analysis and Calorimetry. 132:1783-1794
In this paper, the co-pyrolysis characteristic of wet sewage sludge (60 mass%) with sawdust (40 mass%) at high temperature was investigated by Py–GC/MS and a bench-scale screw moving bed reactor. The Py–GC/MS analysis indicated that the main pyro
Autor:
Feng Liang, Cai Mingzhi, Ke Wu, Guangkuo Zhu, Yingquan Chen, Gao Ying, Jinjiao Zhu, Qiaoxia Yuan
Publikováno v:
Journal of Analytical and Applied Pyrolysis. 127:335-342
The effects of reaction tempreture on hydrochar and aqueous phase products were investigated in this paper. The hydrochars were obtained from hydrothermal carbonization of dairy manure at 200–280 °C for 4 h (maintain 1:20 manure-to-water ratio, st
Autor:
Qiai You, Yongxin Yu, Feng Li, Jianguo Sun, Guangkuo Zhu, Zhengtang Chen, Qiao Yang, Zihan Xu, Jianmin Wang, Xu-Dong Wang, Pu Zhou, Wenlei Zhuo, Linpeng Zheng
Publikováno v:
Cell Proliferation
Objectives Epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI) has significant therapeutic efficacy in non‐small‐cell lung cancer (NSCLC) patients. However, acquired resistance is inevitable and limits the long‐term efficacy
Autor:
Jianmin Wang, Zhoufei Wang, Guangkuo Zhu, Huiwen Ma, Liqin Xia, Huake Sun, Jianguo Sun, Zhengtang Chen
Publikováno v:
Tumor Biology, Vol 39 (2017)
Acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors, such as gefitinib and erlotinib, is a critical issue in the treatment of patients with epidermal growth factor receptor mutant–positive non–small-cell lung cancer